| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0007 |